Status:
UNKNOWN
Human Papillomavirus and Oropharynx Carcinoma
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Oropharyngeal Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
High risk papillomavirus (HR-HPV) have an oncogenic role in Oropharyngeal squamous cell carcinomas (OP-SCC) in at least 25% of the cases and the prevalence is increasing. HPV+ might be more chemo and ...
Detailed Description
The study has no impact on the treatment of the observed population. The clinical study include TNM status, previous story of HPV infection, smoking and alcoholic habits, treatment and outcome during ...
Eligibility Criteria
Inclusion
- Squamous cell carcinoma of Oropharynx proven histologically
- All stages TNM
- informed consent
- No previous or simultaneous Head Neck cancer
- Age \>18
Exclusion
- Squamous cell carcinoma other than oropharynx
- 2nd synchronous SCC localization
- No consent
- age \< 18
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
362 Patients enrolled
Trial Details
Trial ID
NCT00918710
Start Date
May 1 2009
End Date
May 1 2017
Last Update
April 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tenon Hospital, APHP
Paris, France, 75020